- Home
- Equipment
- usa massachusetts
- intravenous anesthesia tiva administration
Refine by
Intravenous Anesthesia Tiva Administration Equipment Supplied In Usa Massachusetts
7 equipment items found
Manufactured by:NxStage Medical, Inc. based inLawrence, MASSACHUSETTS (USA)
The Medic anti-stick needle connector is a safe, easy, and cost effective way of reducing the use of sharps in your ...
Manufactured by:SQ Innovation, Inc. based inBurlington, MASSACHUSETTS (USA)
Lasix ONYU is an advanced prescription drug-device combination designed specifically for the treatment of edema in adults suffering from chronic heart failure. This innovative product represents a shift from traditional oral and intravenous methods by introducing a high-concentration formulation of furosemide for subcutaneous infusion. Each prefilled cartridge within the device delivers 80 mg of ...
Manufactured by:Alphageneron based inCambridge, MASSACHUSETTS (USA)
An allogenic NK cell therapy that targets tumors expressing mHsp70. Patients are selected with high mHsp70 exosomes in their blood using our Companion Diagnostic AP-CDx (described below). We obtain PBMCs from healthy donors by apheresis, their NK cells are expanded, and incubated ex vivo with TKD and IL-2, followed by freezing, thawing and intravenous administration to ...
by:Aphios Corporation based inWoburn, MASSACHUSETTS (USA)
A combination therapy consisting of PKC agonists with or without HDAC inhibitors, designed to reactivate latent HIV reservoirs so that HIV can be eliminated by antiviral therapy and eradicated from the body. HIV Latency: Although highly active antiretroviral therapy (HAART) is undoubtedly a lifesaving therapy for millions of AIDS patients, the persistence of latent HIV-infected cellular ...
Manufactured by:Eagle Pharmaceuticals, Inc. based inWoodcliff Lake, NEW JERSEY (USA)
Indication: PEMFEXY is indicated in combination with cisplatin for the initial treatment of patients with locally advanced or metastatic non-squamous non-small cell lung cancer (NSCLC). PEMFEXY is indicated as a single agent for the maintenance treatment of patients with locally advanced or metastatic non-squamous non-small cell lung cancer (NSCLC) whose disease has not progressed after four ...
Manufactured by:Biotest AG based inDreieich, GERMANY
At the ISTH 2020 Biotest presented its novel recombinant Factor VIII molecules overcoming the major challenges of current Factor VIII replacement therapy by combining a significantly extended half-life, low immunogenicity and the possibility of either subcutaneous or intravenous ...
Manufactured by:Biotest AG based inDreieich, GERMANY
Trimodulin (BT588, predecessor BT086) is a human plasma-derived native polyvalent antibody preparation for intravenous administration. Trimodulin contains immunoglobulins IgM (-23%), IgA (~ 21%) and igG (-56%). Trimodulin mediates its mode of action via three potential mechanisms which are; opsonization of causal pathogens, neutralizing of microbial pathogens and their virulence factors (endo- ...